1. Home
  2. ZYBT vs MRVI Comparison

ZYBT vs MRVI Comparison

Compare ZYBT & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYBT
  • MRVI
  • Stock Information
  • Founded
  • ZYBT 2004
  • MRVI 2014
  • Country
  • ZYBT China
  • MRVI United States
  • Employees
  • ZYBT N/A
  • MRVI N/A
  • Industry
  • ZYBT
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZYBT
  • MRVI Health Care
  • Exchange
  • ZYBT NYSE
  • MRVI Nasdaq
  • Market Cap
  • ZYBT 340.3M
  • MRVI 312.4M
  • IPO Year
  • ZYBT 2025
  • MRVI 2020
  • Fundamental
  • Price
  • ZYBT $5.55
  • MRVI $2.69
  • Analyst Decision
  • ZYBT
  • MRVI Hold
  • Analyst Count
  • ZYBT 0
  • MRVI 10
  • Target Price
  • ZYBT N/A
  • MRVI $6.84
  • AVG Volume (30 Days)
  • ZYBT 77.0K
  • MRVI 1.9M
  • Earning Date
  • ZYBT 07-03-2025
  • MRVI 08-06-2025
  • Dividend Yield
  • ZYBT N/A
  • MRVI N/A
  • EPS Growth
  • ZYBT N/A
  • MRVI N/A
  • EPS
  • ZYBT 0.03
  • MRVI N/A
  • Revenue
  • ZYBT $25,531,367.00
  • MRVI $241,856,000.00
  • Revenue This Year
  • ZYBT N/A
  • MRVI N/A
  • Revenue Next Year
  • ZYBT N/A
  • MRVI $10.91
  • P/E Ratio
  • ZYBT $163.55
  • MRVI N/A
  • Revenue Growth
  • ZYBT N/A
  • MRVI N/A
  • 52 Week Low
  • ZYBT $3.50
  • MRVI $1.67
  • 52 Week High
  • ZYBT $14.30
  • MRVI $10.03
  • Technical
  • Relative Strength Index (RSI)
  • ZYBT N/A
  • MRVI 58.67
  • Support Level
  • ZYBT N/A
  • MRVI $2.35
  • Resistance Level
  • ZYBT N/A
  • MRVI $2.93
  • Average True Range (ATR)
  • ZYBT 0.00
  • MRVI 0.17
  • MACD
  • ZYBT 0.00
  • MRVI -0.01
  • Stochastic Oscillator
  • ZYBT 0.00
  • MRVI 58.97

About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD

Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: